Home / Aflibercept / Norway
NO ATC S01LA05 · updated 2 Nov 2026
Aflibercept shortage in Norway
Is there an Aflibercept shortage in Norway?
Yes. As of 2 Nov 2026, 2 Aflibercept products are reported short in Norway, the first since 16 Oct 2026. The company estimate for the return is 24 Nov 2026 (latest 30 Sep 2027). Main reason: commercial decision or withdrawal.
Also short in Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Eylea 40 mg/ml injeksjonsvæske, oppløsning, 0 ml ferdigfylt sprøyte | Bayer AG | 16 Oct 2026 | 30 Sep 2027 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Eylea 40 mg/ml injeksjonsvæske, oppløsning, 0 ml hetteglass | Bayer AG | 16 Oct 2026 | 24 Nov 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).